Skip to content

Studying the effect of royal jelly on the treatment of tinnitus

Evaluating the Efficacy of Royal Jelly Compared to Placebo in Improving Tinnitus in Affected Patients: Randomized controlled trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240327061371N3
Enrollment
60
Registered
2025-05-26
Start date
2025-05-31
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus. Tinnitus

Interventions

Intervention 1: Intervention group: Participants in this group will receive an oral syrup containing royal jelly once daily for 30 consecutive days. Each dose consists of 10 milliliters of syrup per d

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Tinnitus and confirmation of the condition based on clinical diagnosis by an otolaryngologist and based on audiometry results (audiometry including tinnitus frequency) No history of allergy to royal jelly. No history of mental disorders or use of stimulant medications Not having hearing loss or deafness or using hearing aids Avoid taking ototoxic medications.

Exclusion criteria

Exclusion criteria: Concomitant use of other treatment strategies Unwillingness to participate in the study Allergy to royal jelly Organic causes, if diagnosed, such as Meniere's disease and acoustic neuroma Unilateral Tinnitus

Design outcomes

Primary

MeasureTime frame
Tinnitus severity based on the total score of the “Tinnitus Handicap Inventory” questionnaire, which assesses the impact of tinnitus on patients’ daily life. Timepoint: Tinnitus severity score will be measured at baseline (before the intervention) and at weeks 1, 3, 6, and 12 after the start of royal jelly syrup consumption. Method of measurement: Tinnitus severity will be assessed using the validated Persian version of the “Tinnitus Handicap Inventory” questionnaire, consisting of 25 questions rated on a five-point Likert scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfrooz Eshaghian

Esfahan University of Medical Sciences

afroozeshaghian@med.mui.ac.ir+98 31 3233 0092

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026